510(k) K032254

IBL C1Q-CIC CIA TEST by Ibl GmbH — Product Code DAK

K032254 is an FDA 510(k) premarket notification submitted by Ibl GmbH for the device "IBL C1Q-CIC CIA TEST". The FDA issued a decision of Substantially Equivalent on Aug 29, 2003. The device falls under product code DAK (Complement C1q, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5240. Ibl GmbH has 5 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Aug 29, 2003
Date Received
Jul 22, 2003
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Complement C1q, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
866.5240
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Ibl GmbH? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K032254. Report a data issue: hello@regdatalab.com.